{ "format" : "linked-data-api", "version" : "0.2", "result" : {"_about" : "http://eldaddp.azurewebsites.net/answeredquestions.text?answer.dateOfAnswer=2014-10-29&hansardHeading=Osteoporosis", "definition" : "http://eldaddp.azurewebsites.net/meta/answeredquestions.text?answer.dateOfAnswer=2014-10-29&hansardHeading=Osteoporosis", "extendedMetadataVersion" : "http://eldaddp.azurewebsites.net/answeredquestions.text?answer.dateOfAnswer=2014-10-29&_metadata=all&hansardHeading=Osteoporosis", "first" : "http://eldaddp.azurewebsites.net/answeredquestions.text?_page=0&answer.dateOfAnswer=2014-10-29&hansardHeading=Osteoporosis", "hasPart" : "http://eldaddp.azurewebsites.net/answeredquestions.text?answer.dateOfAnswer=2014-10-29&hansardHeading=Osteoporosis", "isPartOf" : "http://eldaddp.azurewebsites.net/answeredquestions.text?answer.dateOfAnswer=2014-10-29&hansardHeading=Osteoporosis", "items" : [{"_about" : "http://data.parliament.uk/resources/100721", "AnsweringBody" : [{"_value" : "Department of Health"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/100721/answer", "answerText" : {"_value" : "

The following table shows estimated expenditure on research on asthma, motor neurone disease (MND) and osteoporosis by the Medical Research Council, other Research Councils and Innovate UK, and by the National Institute for Health (NIHR) through its research programmes, research centres and units, and research fellowships.<\/p>

<\/p>

<\/p>

<\/p>

£ million<\/em><\/p>

<\/p>
<\/td>

2009-10<\/p><\/td>

2010-11<\/p><\/td>

2011-12<\/p><\/td>

2012-13<\/p><\/td>

2013-14<\/p><\/td><\/tr>

Asthma<\/p><\/td><\/tr>

Medical Research Council<\/p><\/td>

22.2 <\/del>6.6<\/ins><\/p><\/td>

17.5 <\/del>5.3<\/ins><\/p><\/td>

17.2<\/del> 4.5<\/ins><\/p><\/td>

19.4<\/del> 3.6<\/ins><\/p><\/td>

18.8<\/del> 5.4<\/ins><\/p><\/td><\/tr>

Other Research Councils and Innovate UK<\/p><\/td>

0.0<\/p><\/td>

0.1<\/p><\/td>

0.3<\/p><\/td>

1.5<\/p><\/td>

0.8<\/p><\/td><\/tr>

National Institute for Health Research<\/p><\/td>

2.6<\/p><\/td>

3.4<\/p><\/td>

2.4<\/p><\/td>

3.4<\/p><\/td>

3.8<\/p><\/td><\/tr>

Total<\/p><\/td>

24.8<\/del> 9.2<\/ins><\/p><\/td>

21.0<\/del> 8.8<\/ins><\/p><\/td>

19.9<\/del> 7.2<\/ins><\/p><\/td>

24.3 <\/del>8.5<\/ins><\/p><\/td>

23.4<\/del> 10.0<\/ins><\/p><\/td><\/tr>

Motor Neurone Research<\/p><\/td><\/tr>

Medical Research Council<\/p><\/td>

7.0<\/p><\/td>

7.5<\/p><\/td>

4.2<\/p><\/td>

4.1<\/p><\/td>

3.6<\/p><\/td><\/tr>

Other Research Councils and Innovate UK<\/p><\/td>

0.2<\/p><\/td>

0.2<\/p><\/td>

0.4<\/p><\/td>

0.7<\/p><\/td>

1.0<\/p><\/td><\/tr>

National Institute for Health Research<\/p><\/td>

0.1<\/p><\/td>

0.1<\/p><\/td>

0.4<\/p><\/td>

0.7<\/p><\/td>

0.5<\/p><\/td><\/tr>

Total<\/p><\/td>

7.3<\/p><\/td>

7.8<\/p><\/td>

5.0<\/p><\/td>

5.5<\/p><\/td>

5.1<\/p><\/td><\/tr>

Osteoporosis<\/p><\/td><\/tr>

Medical Research Council<\/p><\/td>

6.2<\/p><\/td>

5.4<\/p><\/td>

5.1<\/p><\/td>

4.6<\/p><\/td>

5.9<\/p><\/td><\/tr>

Other Research Councils and Innovate UK<\/p><\/td>

0.0<\/p><\/td>

0.0<\/p><\/td>

0.1<\/p><\/td>

0.4<\/p><\/td>

1.0<\/p><\/td><\/tr>

National Institute for Health Research<\/p><\/td>

0.3<\/p><\/td>

0.7<\/p><\/td>

0.8<\/p><\/td>

1.3<\/p><\/td>

1.8<\/p><\/td><\/tr>

Total<\/p><\/td>

6.5<\/p><\/td>

6.1<\/p><\/td>

6.0<\/p><\/td>

6.3<\/p><\/td>

8.7<\/p><\/td><\/tr><\/tbody><\/table>

<\/p>

<\/p>

<\/p>

The figures shown for asthma exclude research into air pollution and potential effects on health outcomes including asthma.<\/p>

<\/p>

<\/p>

<\/p>

Total spend by the NIHR on asthma, MND and osteoporosis is higher than the figures shown because expenditure by the NIHR Clinical Research Network (CRN) on these diseases cannot be disaggregated from total CRN expenditure. NIHR expenditure relating to development of new drugs for asthma, MND and osteroporosis occurs primarily through NIHR research infrastructure including the CRN and cannot be disaggregated from total expenditure.<\/p>

<\/p>

<\/p>

<\/p>

Information on MRC expenditure into the development of new drugs for asthma, MND or osteoporosis is not available.<\/p>

<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4020", "label" : {"_value" : "Biography information for George Freeman"} } , "answeringMemberConstituency" : {"_value" : "Mid Norfolk"} , "answeringMemberPrinted" : {"_value" : "George Freeman"} , "dateOfAnswer" : {"_value" : "2014-10-29", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "true", "_datatype" : "boolean"} , "previousAnswerVersion" : {"_about" : "http://data.parliament.uk/resources/100721/answer/previousversion/25123", "answeringMember" : {"_about" : "http://data.parliament.uk/members/4020", "label" : {"_value" : "Biography information for George Freeman"} } , "answeringMemberConstituency" : {"_value" : "Mid Norfolk"} , "answeringMemberPrinted" : {"_value" : "George Freeman"} } , "questionFirstAnswered" : [{"_value" : "2014-10-29T17:12:28.3318918Z", "_datatype" : "dateTime"} ], "questionFirstMinisteriallyCorrected" : [{"_value" : "2014-11-13T10:22:56.0372213Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health"} , "answeringDeptSortName" : {"_value" : "Health"} , "date" : {"_value" : "2014-10-23", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Osteoporosis"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health, how much from the publich purse has been spent on research into osteoporosis in each of the last five years.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4026", "label" : {"_value" : "Biography information for Liz Kendall"} } , "tablingMemberConstituency" : {"_value" : "Leicester West"} , "tablingMemberPrinted" : [{"_value" : "Liz Kendall"} ], "uin" : "211732"} ], "itemsPerPage" : 10, "page" : 0, "startIndex" : 1, "totalResults" : 1, "type" : ["http://purl.org/linked-data/api/vocab#ListEndpoint", "http://purl.org/linked-data/api/vocab#Page"]} }